AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 64 filers reported holding AVROBIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 320 | -97.4% | 0.00% | – |
| Q1 2022 | $16,000 | -66.0% | 12,320 | 0.0% | 0.00% | – |
| Q4 2021 | $47,000 | -31.9% | 12,320 | -0.2% | 0.00% | – |
| Q3 2021 | $69,000 | -72.8% | 12,346 | -56.8% | 0.00% | – |
| Q2 2021 | $254,000 | -29.2% | 28,601 | +1.1% | 0.00% | – |
| Q1 2021 | $359,000 | -9.1% | 28,300 | 0.0% | 0.00% | – |
| Q4 2020 | $395,000 | +7.3% | 28,300 | 0.0% | 0.00% | – |
| Q3 2020 | $368,000 | -25.5% | 28,300 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $494,000 | +75.2% | 28,300 | +56.4% | 0.00% | – |
| Q1 2020 | $282,000 | -22.5% | 18,100 | 0.0% | 0.00% | – |
| Q4 2019 | $364,000 | +42.2% | 18,100 | 0.0% | 0.00% | – |
| Q3 2019 | $256,000 | +23.1% | 18,100 | +41.4% | 0.00% | – |
| Q2 2019 | $208,000 | +38.7% | 12,800 | +88.2% | 0.00% | – |
| Q1 2019 | $150,000 | +32.7% | 6,800 | 0.0% | 0.00% | – |
| Q4 2018 | $113,000 | – | 6,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,236,123 | $21,570,000 | 14.96% |
| Aisling Capital Management LP | 1,009,779 | $17,621,000 | 6.72% |
| Burrage Capital Management LLC | 225,900 | $3,942,000 | 2.76% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $5,506,000 | 1.58% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $13,960,000 | 1.36% |
| Camber Capital Management LP | 1,350,000 | $23,558,000 | 1.35% |
| Parkman Healthcare Partners LLC | 190,593 | $3,326,000 | 0.94% |
| Eventide Asset Management | 1,905,307 | $33,248,000 | 0.72% |
| Penn Mutual Asset Management | 37,306 | $651,000 | 0.66% |
| EMERALD ADVISERS, LLC | 832,474 | $14,527,000 | 0.63% |